CVS to begin selling topical CBD products, but holds off on supplements

Curaleaf Holdings, Inc. (Wakefield, MA) announced during an earnings call that it has developed an agreement with CVS Health Corp. to begin selling its CBD products in CVS stores. The products, which include creams, sprays, and lotions infused with CBD, will be sold in 800 stores across eight states, including California, Illinois, Colorado, and Alabama. Notably, however, the pharmacy chain will not be selling any CBD products marketed as dietary supplements or foods fortified with CBD. In addition to a lineup of CBD-based lotions, tinctures, and vape pens as part of its Curaleaf Hemp line, the company also manufactures medical-grade cannabis products for the legal marijuana markets, operating 40 marijuana dispensaries across 12 states.